Morbidity and mortality following poliomyelitis: a lifelong follow-up

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Morbidity and mortality following poliomyelitis : a lifelong follow-up. / Kay, L; Nielsen, N M; Wanscher, B; Ibsen, R; Kjellberg, J; Jennum, P.

In: European Journal of Neurology, Vol. 24, No. 2, 2017, p. 326-333.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Kay, L, Nielsen, NM, Wanscher, B, Ibsen, R, Kjellberg, J & Jennum, P 2017, 'Morbidity and mortality following poliomyelitis: a lifelong follow-up', European Journal of Neurology, vol. 24, no. 2, pp. 326-333. https://doi.org/10.1111/ene.13201

APA

Kay, L., Nielsen, N. M., Wanscher, B., Ibsen, R., Kjellberg, J., & Jennum, P. (2017). Morbidity and mortality following poliomyelitis: a lifelong follow-up. European Journal of Neurology, 24(2), 326-333. https://doi.org/10.1111/ene.13201

Vancouver

Kay L, Nielsen NM, Wanscher B, Ibsen R, Kjellberg J, Jennum P. Morbidity and mortality following poliomyelitis: a lifelong follow-up. European Journal of Neurology. 2017;24(2):326-333. https://doi.org/10.1111/ene.13201

Author

Kay, L ; Nielsen, N M ; Wanscher, B ; Ibsen, R ; Kjellberg, J ; Jennum, P. / Morbidity and mortality following poliomyelitis : a lifelong follow-up. In: European Journal of Neurology. 2017 ; Vol. 24, No. 2. pp. 326-333.

Bibtex

@article{5cf0186530504c849aea92beb73e1021,
title = "Morbidity and mortality following poliomyelitis: a lifelong follow-up",
abstract = "BACKGROUND AND PURPOSE: In the world today 10-20 million people are still living with late effects of poliomyelitis (PM), but the long-term consequences of the disease are not well known. The aim of this study was to describe lifelong morbidity and mortality among Danes who survived PM.METHODS: Data from official registers for a cohort of 3606 Danes hospitalized for PM in the period 1940-1954 were compared with 13 762 age- and gender-matched controls.RESULTS: Compared with controls, mortality was moderately increased for both paralytic as well as non-paralytic PM cases; Hazard Ratio, 1.31 (95% confidence interval, 1.18-1.44) and 1.09 (95% confidence interval, 1.00-1.19), respectively. Hospitalization rates were approximately 1.5 times higher among both paralytic and non-paralytic PM cases as compared with controls. Discharge diagnoses showed a broad spectrum of diseases. There were no major differences in morbidities between paralytic and non-paralytic PM cases.CONCLUSIONS: Poliomyelitis has significant long-term consequences on morbidity and mortality of both paralytic and non-paralytic cases.",
keywords = "Age Factors, Aged, Aged, 80 and over, Denmark/epidemiology, Female, Follow-Up Studies, Hospitalization/statistics & numerical data, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Paralysis/complications, Poliomyelitis/epidemiology",
author = "L Kay and Nielsen, {N M} and B Wanscher and R Ibsen and J Kjellberg and P Jennum",
note = "{\textcopyright} 2016 EAN.",
year = "2017",
doi = "10.1111/ene.13201",
language = "English",
volume = "24",
pages = "326--333",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",
number = "2",

}

RIS

TY - JOUR

T1 - Morbidity and mortality following poliomyelitis

T2 - a lifelong follow-up

AU - Kay, L

AU - Nielsen, N M

AU - Wanscher, B

AU - Ibsen, R

AU - Kjellberg, J

AU - Jennum, P

N1 - © 2016 EAN.

PY - 2017

Y1 - 2017

N2 - BACKGROUND AND PURPOSE: In the world today 10-20 million people are still living with late effects of poliomyelitis (PM), but the long-term consequences of the disease are not well known. The aim of this study was to describe lifelong morbidity and mortality among Danes who survived PM.METHODS: Data from official registers for a cohort of 3606 Danes hospitalized for PM in the period 1940-1954 were compared with 13 762 age- and gender-matched controls.RESULTS: Compared with controls, mortality was moderately increased for both paralytic as well as non-paralytic PM cases; Hazard Ratio, 1.31 (95% confidence interval, 1.18-1.44) and 1.09 (95% confidence interval, 1.00-1.19), respectively. Hospitalization rates were approximately 1.5 times higher among both paralytic and non-paralytic PM cases as compared with controls. Discharge diagnoses showed a broad spectrum of diseases. There were no major differences in morbidities between paralytic and non-paralytic PM cases.CONCLUSIONS: Poliomyelitis has significant long-term consequences on morbidity and mortality of both paralytic and non-paralytic cases.

AB - BACKGROUND AND PURPOSE: In the world today 10-20 million people are still living with late effects of poliomyelitis (PM), but the long-term consequences of the disease are not well known. The aim of this study was to describe lifelong morbidity and mortality among Danes who survived PM.METHODS: Data from official registers for a cohort of 3606 Danes hospitalized for PM in the period 1940-1954 were compared with 13 762 age- and gender-matched controls.RESULTS: Compared with controls, mortality was moderately increased for both paralytic as well as non-paralytic PM cases; Hazard Ratio, 1.31 (95% confidence interval, 1.18-1.44) and 1.09 (95% confidence interval, 1.00-1.19), respectively. Hospitalization rates were approximately 1.5 times higher among both paralytic and non-paralytic PM cases as compared with controls. Discharge diagnoses showed a broad spectrum of diseases. There were no major differences in morbidities between paralytic and non-paralytic PM cases.CONCLUSIONS: Poliomyelitis has significant long-term consequences on morbidity and mortality of both paralytic and non-paralytic cases.

KW - Age Factors

KW - Aged

KW - Aged, 80 and over

KW - Denmark/epidemiology

KW - Female

KW - Follow-Up Studies

KW - Hospitalization/statistics & numerical data

KW - Humans

KW - Kaplan-Meier Estimate

KW - Male

KW - Middle Aged

KW - Paralysis/complications

KW - Poliomyelitis/epidemiology

U2 - 10.1111/ene.13201

DO - 10.1111/ene.13201

M3 - Journal article

C2 - 27869331

VL - 24

SP - 326

EP - 333

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 2

ER -

ID: 195162697